-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Tyra Biosciences, Raises Price Target to $57

Benzinga·11/11/2026 14:10:10
Wedbush analyst Robert Driscoll maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target from $53 to $57.